Hangzhou, China · Founded 2021 · Privately Held (backing)
Developer of innovative drug designed for nervous system disease. Biyo Pharma is based in Hangzhou, China and was founded in 2021. It has raised $14.3 million.
Last price · $/share
—
Implied valuation
—
Total raised
$14.3M
Last round
—
Cap table — not yet on record
Biyo Pharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Biyo Pharma with a free account
·Watch Biyo Pharma: the Monday email on marks, rounds and moves
